Amylyx Pharmaceuticals, Inc. (AMLX)
13.99
-0.39
(-2.71%)
USD |
NASDAQ |
Mar 13, 16:00
13.72
-0.27
(-1.93%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Liabilities (Quarterly) : 28.82M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Disc Medicine, Inc. | 67.05M |
| Cytokinetics, Inc. | 2.084B |
| Ionis Pharmaceuticals, Inc. | 3.035B |
| MediciNova, Inc. | 4.016M |
| Scholar Rock Holding Corp. | 158.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 334.07M |
| Shareholders Equity (Quarterly) | 305.26M |
| Debt to Equity Ratio | 0.0195 |
| Current Ratio | 14.27 |
| Net Debt Paydown Yield | -0.05% |